1 Caraceni A,Hanks G,Kaasa S,et al.Use of poioid analgesics in the treatment of cancer pain:evidence-based recommendations from the EAPC[J].Lancet Oncol,2012,13(2):e58-e68. 2 Fitzgibbon D.Inerventional procedures for cancer pain management;selecting the right procedure at the right time[J].J Supp Oncol,2010,8(2):60-61. 3 Schmidt P.Morphine equivalent dose and analgesic equivalents:understanding the difference[J].J Pain,2016,17(4):86. 4 Van den Beuken-van Everdingen MH,de Rijke JM,Kessels AG,et al.Prevalence of pain in patients with cancer:a systematic review of the past 40 years[J].Ann Oncol,2007,18(9):1437-1449. 5 Portenoy RK,Hagen NA.Breakthrough pain:definition and management[J].Oncology(Williston Park),1989,3(8Suppl):25-29. 6 Thomas WL,Lynn JH,Amy PA.Breakthrough cancer pain[J].Supp Cancer Care,2016,2(2):127-137. 7 高宏,殷东风,刑玉庆,等.持续皮下注射吗啡治疗晚期肿瘤中重度癌痛的阵痛效果研究[J].肿瘤药学,2011,1(2):101-103. 8 田华,向登国.微量泵皮下自控阵痛治疗晚期癌痛30例疗效观察[J].中国医药导报,2011,8(33):86-87. 9 Schiessl C,Schestag I,Sittl R,et al.Rhythmic pattern of PCA opioid demand in adults with cancer pain[J].Eur J Pain,2010,14:372-379. 10 李迅,于文源.吗啡控释片与吗啡注射液在治疗中重度癌痛中的疗效分析[J].中国现代药物应用,2007,1(12):40-41. |